PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

NCT05060471 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Anal Canal Cancer
Anal Squamous Cell Carcinoma
Anal Cancer
Anal Canal Cancer Stage I
Anal Canal Cancer Stage II
Anal Canal Cancer Stage III

Interventions

DRUG: Toripalimab

Sponsor

Sun Yat-sen University